Skip to main content

Table 1 Clinical and laboratory data of 20 pubertal boys with short stature before GH/Letrozole treatment

From: Adult height in pubertal boys with short stature treated with GH/letrozole: a hospital record-based retrospective study

Subject No. Age-ranges (y) BMI (kg/m2) Height SDS for CA Bone age(y) Height SDS for bone age Testis volume(ml) Tanner stage Testosterone(ng/ml) Estradiol (pg/ml) Target height (cm)
1 11–14 25.8 -1.33 13.9 -2.37 25.0 5 2.08 21.00 166.5
2 11–14 26.2 0.33 14.4 -1.42 25.0 5 3.22 25.00 166.5
3 9–12 19.5 0.32 13.4 -1.83 10.0 3 2.16 26.00 165.8
4 11–14 15.7 -2.64 12.9 -2.42 6.0 2 0.77 39.00 168.5
5 9–12 17.7 -0.02 12.3 -1.28 16.0 4 4.96 54.00 165.0
6 10–13 20.4 -0.97 12.6 -1.66 8.0 2 0.58 6.00 167.5
7 10–13 18.9 -0.95 12.4 -1.49 6.5 2 0.93 1.00 173.0
8 10–13 19.1 -0.92 12.7 -1.36 8.0 2 3.51 69.00 169.0
9 10–13 23.6 0.54 12.8 -0.55 15.0 4 1.59 7.00 167.5
10 9–12 19.5 0.91 13.1 -0.87 18.0 4 0.48 17.28 168.0
11 9–12 21.8 -0.48 12.4 -1.47 4.5 2 1.61 30.00 165.0
12 12–15 17.4 0.26 14.1 -1.01 20.0 4 5.33 25.00 166.0
13 11–14 18.1 -0.79 13.2 -1.58 21.0 4 5.20 9.00 161.2
14 9–12 17.6 0.27 13.0 -1.62 10.5 3 1.91 13.00 176.4
15 12–15 16.8 0.14 15.1 -1.83 10.0 3 4.29 18.30 171.3
16 10–13 20.0 -1.31 12.1 -1.51 8.0 2 0.62 3.00 169.7
17 11–14 23.3 -0.08 13.4 -1.13 8.0 2 2.04 19.00 165.5
18 9–12 15.1 -1.58 10.8 -1.45 4.0 2 0.19 9.00 167.5
19 9–12 20.4 -0.41 12.3 -1.88 6.0 2 0.22 26.00 162.0
20 11–14 18.6 0.09 13.0 -0.39 18.0 4 1.64 17.00 171.5
  1. GH Growth hormone, No. Number, SDS Standard deviation score, BMI body mass index, CA Chronological age